Takeda Pharmaceutical (TAK)

• Market cap: $47.8B
• 1 day: -0.2%
• 5 days: -0.59%
• 1 month: -0.46%
• 3 months: 1.34%
• 6 months: -0.59%
• Year to date: 13.89%
• 1 year: 1.62%
• 5 years: -19.9%
• 10 years: -9.31%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Employees: 47,455

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

12,219% more call options, than puts

Call options by funds: $26.6M | Put options by funds: $216K

108% more repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 65

53% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 32

14% more capital invested

Capital invested by funds: $1.06B [Q1] → $1.2B (+$147M) [Q2]

2% more funds holding

Funds holding: 303 [Q1] → 309 (+6) [Q2]

2.02% less ownership

Funds ownership: 4.47% [Q1] → 2.45% (-2.02%) [Q2]